The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway

Transforming growth factor-β pathway activity in glioblastoma

(2015) Karl Frei et al.   Oncotarget

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape

(2015) Paula Codo et al.   Oncotarget

The Aryl Hydrocarbon Receptor: Multitasking in the Immune System

(2014) Brigitta Stockinger et al.   Annual Review of Immunology

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer

(2014) Jordi Rodón et al.   INVESTIGATIONAL NEW DRUGS

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

(2014) Roger Stupp et al.   LANCET ONCOLOGY

Integrin inhibition promotes atypical anoikis in glioma cells

(2014) M Silginer et al.   Cell Death & Disease

Integrin control of the transforming growth factor-β pathway in glioblastoma

(2013) Patrick Roth et al.   BRAIN

Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma

(2013) Hans-Georg Wirsching et al.   BRAIN

Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target

(2013) Stephen Safe et al.   TOXICOLOGICAL SCIENCES

TGF-β as a therapeutic target in high grade gliomas – Promises and challenges

(2012) Justin V. Joseph et al.   BIOCHEMICAL PHARMACOLOGY

Semi-quantitative immunohistochemical assay versus oncotype DX® qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study

(2012) James A Kraus et al.   MODERN PATHOLOGY

Matched rabbit monoclonal antibodies against  v-series integrins reveal a novel  v 3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors

(2012) S. L. Goodman et al.   Biology Open

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

(2011) Christiane A. Opitz et al.   NATURE

The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth

(2010) C. Dietrich et al.   CARCINOGENESIS

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

(2009) Gabriele D. Maurer et al.   NEURO-ONCOLOGY

Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells

(2009) D Gramatzki et al.   ONCOGENE

The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism

(2008) Tiffany Kung et al.   BIOCHEMICAL PHARMACOLOGY

The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor

(2007) Linh P. Nguyen et al.   CHEMICAL RESEARCH IN TOXICOLOGY